Monday, May 26, 2008

Novartis MS Drug, Rival to Bayer's, Wins EU Approval (Update3) - Bloomberg - SendMeRSS


Novartis MS Drug, Rival to Bayer's, Wins EU Approval (Update3)
Bloomberg - 58 minutes ago
By Eva von Schaper and Dermot Doherty May 26 (Bloomberg) -- Novartis AG won European approval for a multiple sclerosis drug that's identical to Bayer AG's Betaseron, the German company's second best-selling medicine.
UPDATE 1-Novartis' MS drug gets approval in EU Reuters
Novartis' Extavia gains EU approval for multiple sclerosis treatment Forbes
ABN Newswire (press release) - Ad-Hoc-News (Pressemitteilung) - Bloomberg
all 17 news articles
(full text retrieval failed)
Link - Sun, 25 May 2008 19:34:31 GMT - Feed (1 subs)
Sent using SendMeRss.com.
Visit here to unsubscribe from Google News - Business.
Recommended Feeds/Actions
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)